ONLY FOR USA CUSTOMERS (Unfortunately we're not available to ship this test to patients located in New York, New Jersey, Rhode Island or internationally yet)
Research shows that gut health impacts overall health. In particular, the gut microbiome plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic, and neuroendocrine functions. Assessing your gastrointestinal tract using appropriate tools can help identify the underlying causes of chronic diseases.
GI-MAP is a unique test in the field of comprehensive stool analysis. It relies solely on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi and other microorganisms by targeting the specific DNA of the organisms being tested. It identifies microbial imbalances, microbes that contribute to disease, as well as indicators of digestion, absorption, inflammation and immune function. The test also includes antibiotic resistance genes and virulence factors, providing unique information about H. pylori.
GI-MAP was developed to identify microbes that may disrupt normal microbial balance or contribute to the development of disease. To complete the picture of overall health, the GI-MAP includes key markers related to digestion, absorption, inflammation and immune function.
An unhealthy gut can cause unpleasant symptoms that are felt beyond the gastrointestinal (GI) tract. In fact, the root cause of brain fog, fatigue, headaches, food sensitivities, etc. often there may be intestines.
GI-MAP produces impressive quantitative results that allow clinicians to create customized protocols that address the underlying cause(s) of uncomfortable symptoms in even the most challenging patients.
Why is quantification using qPCR technology important?
qPCR provides a much more accurate way to detect and quantify clinically relevant organisms than standard PCR, culture, microscopy, or DNA sequencing methods. Accurate assessment of the amount of DNA of a particular microorganism in a patient's stool sample is very important for determining the clinical significance of pathogenic microorganisms and dysbiosis.
GI-MAP allows you to create personalized treatment plans aimed at improving your gut health, taking into account which infections are a priority, which parts of the gut are already optimized, and which should be treated once the infection has resolved.
In addition, quantification provides an excellent opportunity to see how effective treatments are, since repeat testing after treatment can show whether the parasite has been eliminated, dysbiosis has improved, etc.
Who benefits from the GI-MAP comprehensive stool analysis?
With a comprehensive gut health assessment, virtually every patient can benefit from a GI-MAP gut health assessment. GI-MAP is ideal for patients wanting to optimize their health and is a critical test for patients who are chronically ill and go years without a diagnosis.
Conditions that require testing include:
- Autoimmune diseases
- Irritable bowel syndrome (IBS)
- Inflammatory bowel diseases
- Digestive complaints (bloating, diarrhea or constipation)
- Brain fog
- Skin problems such as acne and psoriasis
- Mood disorders, depression and anxiety
- Diabetes and weight loss problems
What sample is required for the GI-MAP test?
The GI-MAP test is performed on a single stool sample. Collecting a sample is very simple: the patient collects his or her stool and uses the supplied tools to draw some of it into a tube.
This tube is returned to Diagnostic Solutions in an envelope and then analyzed. The analysis results are sent to you by email.
Пример результата исследования
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
